← Back to all trials
Not Yet Recruiting
NCT07647081
The Impacts of Ashwagandha Supplementation on Diurnal Cortisol and Stress Among Women
Conditions: Stress
Sex: Female
Ages: 18 Years – 45 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 30
Sponsor: Oklahoma State University Center for Health Sciences
Summary
The purpose of this project is to better understand the role of ashwagandha on the stress response and wellbeing among healthy, stressed women.
Eligibility Criteria
Inclusion Criteria:
1. Female, ages 18-45
2. No hormonal birth control
3. Identify as having a regular sleep schedule (eg. sleep by 1am and wake by 9am)
4. Identify as having a regular menstrual period between 27-32 days apart on average
5. PSS score of 14 (moderate stress) or greater
6. No expected changes in stress levels over the next 3 months and agree to not initiate any new stress-reduction behaviors before study start or during the study
Exclusion Criteria:
1. Diagnosed major depressive disorder or generalized anxiety disorder in the last 3 months, any liver, kidney, or thyroid disorder/dysfunction/injury, or diabetes
2. Using any medication related to cortisol or HPA function such as corticosteroids, antidepressants, anti-psychotics, CNS-depressants (benzodiazepines, non-benzodiazepine sedatives, barbiturates, anti-convulsants, anesthetics), thyroid medications, diabetic medications, or immunosuppressants
3. Taken any form of ashwagandha within the last 3 months
4. Daily use of alcohol, nicotine, or other substances
5. Who are pregnant, planning to become pregnant, breastfeeding, or have had a hysterectomy
6. Abnormal liver function test value(s) at screening
Source: ClinicalTrials.gov (NCT07647081). StuddyBuddy aggregates publicly available trial information.